UBS Group’s Larimar Therapeutics LRMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$313K Buy
108,337
+63,427
+141% +$183K ﹤0.01% 5195
2025
Q1
$96.6K Sell
44,910
-8,221
-15% -$17.7K ﹤0.01% 5804
2024
Q4
$206K Buy
53,131
+33,257
+167% +$129K ﹤0.01% 5242
2024
Q3
$130K Buy
19,874
+2,202
+12% +$14.4K ﹤0.01% 4986
2024
Q2
$128K Sell
17,672
-8,926
-34% -$64.7K ﹤0.01% 4865
2024
Q1
$202K Sell
26,598
-1,441
-5% -$10.9K ﹤0.01% 4706
2023
Q4
$128K Buy
28,039
+13,986
+100% +$63.6K ﹤0.01% 4855
2023
Q3
$55.5K Sell
14,053
-14,632
-51% -$57.8K ﹤0.01% 5107
2023
Q2
$89.8K Buy
28,685
+22,743
+383% +$71.2K ﹤0.01% 5048
2023
Q1
$26.9K Buy
5,942
+5,870
+8,153% +$26.6K ﹤0.01% 5780
2022
Q4
$297 Sell
72
-3,273
-98% -$13.5K ﹤0.01% 9061
2022
Q3
$11K Buy
3,345
+2,744
+457% +$9.02K ﹤0.01% 7204
2022
Q2
$1K Sell
601
-1,132
-65% -$1.88K ﹤0.01% 8855
2022
Q1
$7K Buy
1,733
+612
+55% +$2.47K ﹤0.01% 7768
2021
Q4
$12K Buy
1,121
+1,113
+13,913% +$11.9K ﹤0.01% 7439
2021
Q3
$0 Hold
8
﹤0.01% 8585
2021
Q2
$0 Hold
8
﹤0.01% 8437
2021
Q1
$0 Sell
8
-291
-97% ﹤0.01% 8098
2020
Q4
$6K Buy
+299
New +$6K ﹤0.01% 6732
2020
Q1
Sell
-87
Closed -$1K 7121
2019
Q4
$1K Sell
87
-1,255
-94% -$14.4K ﹤0.01% 6875
2019
Q3
$12K Buy
+1,342
New +$12K ﹤0.01% 6085
2019
Q2
Sell
-213
Closed -$7K 7061
2019
Q1
$7K Sell
213
-169
-44% -$5.55K ﹤0.01% 6174
2018
Q4
$23K Sell
382
-227
-37% -$13.7K ﹤0.01% 5746
2018
Q3
$85K Buy
609
+387
+174% +$54K ﹤0.01% 4851
2018
Q2
$27K Buy
222
+1
+0.5% +$122 ﹤0.01% 5558
2018
Q1
$20K Buy
221
+80
+57% +$7.24K ﹤0.01% 5541
2017
Q4
$8K Buy
141
+140
+14,000% +$7.94K ﹤0.01% 6185
2017
Q3
$0 Hold
1
﹤0.01% 6847
2017
Q2
$0 Sell
1
-313
-100% ﹤0.01% 6779
2017
Q1
$17K Sell
314
-106
-25% -$5.74K ﹤0.01% 5341
2016
Q4
$16K Sell
420
-23
-5% -$876 ﹤0.01% 5693
2016
Q3
$18K Buy
443
+442
+44,200% +$18K ﹤0.01% 5480
2016
Q2
$0 Sell
1
-127
-99% ﹤0.01% 6864
2016
Q1
$10K Sell
128
-12,825
-99% -$1M ﹤0.01% 5820
2015
Q4
$978K Buy
12,953
+12,021
+1,290% +$908K ﹤0.01% 2704
2015
Q3
$357K Buy
932
+839
+902% +$321K ﹤0.01% 3330
2015
Q2
$39K Buy
93
+76
+447% +$31.9K ﹤0.01% 4954
2015
Q1
$8K Buy
+17
New +$8K ﹤0.01% 5991